These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10328593)

  • 41. Cetuximab in cancers of the lung and head & neck.
    Kim ES; Vokes EE; Kies MS
    Semin Oncol; 2004 Feb; 31(1 Suppl 1):61-7. PubMed ID: 14981582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Manageable early toxicity of cetuximab concurrent with radical radiotherapy for locally advanced head and neck cancer.
    Wieczorek A; Hamid A; O'Toole L
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):496. PubMed ID: 21482459
    [No Abstract]   [Full Text] [Related]  

  • 43. Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
    van Gog FB; Brakenhoff RH; Stigter-van Walsum M; Snow GB; van Dongen GA
    Int J Cancer; 1998 Jul; 77(1):13-8. PubMed ID: 9639387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
    Chan A; Teoh D; Sanghera P; Hartley A
    Radiother Oncol; 2009 Dec; 93(3):654. PubMed ID: 19524312
    [No Abstract]   [Full Text] [Related]  

  • 45. [Role of targeted therapy in the treatment of squamous cell head and neck cancer].
    Gyergyay F
    Magy Onkol; 2007; 51(2):155-7. PubMed ID: 17660872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and Safety of Cetuximab plus Radiotherapy in Cisplatin-Unfit Elderly Patients with Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Study.
    Addeo R; Caraglia M; Vincenzi B; Luce A; Montella L; Mastella A; Mazzone S; Ricciardiello F; Carraturo M; Del Prete S; Sperlongano P
    Chemotherapy; 2019; 64(1):48-56. PubMed ID: 31242489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of cancer of the head and neck--a cocktail with your PORT?
    Saunders MI; Rojas AM
    N Engl J Med; 2004 May; 350(19):1997-9. PubMed ID: 15128901
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma.
    Santarelli A; Lo Russo L; Bambini F; Campisi G; Lo Muzio L
    Minerva Stomatol; 2009 Sep; 58(9):445-52. PubMed ID: 19893469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
    Kovács AF; Mose S; Böttcher HD; Bitter K
    Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concomitant chemoradiation for head and neck cancer: saving lives or grays?
    Henk JM
    Clin Oncol (R Coll Radiol); 2001; 13(5):333-5. PubMed ID: 11716224
    [No Abstract]   [Full Text] [Related]  

  • 54. Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck.
    Levy AR; Johnston KM; Sambrook J; Donato B; Penrod JR; Corral M; Chasen M
    Curr Med Res Opin; 2011 Dec; 27(12):2253-9. PubMed ID: 22017232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
    Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.
    Harari PM; Wheeler DL; Grandis JR
    Semin Radiat Oncol; 2009 Jan; 19(1):63-8. PubMed ID: 19028347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR.
    Laytragoon-Lewin N; Ustun H; Castro J; Friesland S; Ghaderi M; Lundgren J; Turesson I; Lewin F
    J Cancer Res Clin Oncol; 2009 Feb; 135(2):203-9. PubMed ID: 18758819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies.
    Petrelli F; Coinu A; Riboldi V; Borgonovo K; Ghilardi M; Cabiddu M; Lonati V; Sarti E; Barni S
    Oral Oncol; 2014 Nov; 50(11):1041-8. PubMed ID: 25176576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Three cases of head and neck cancer made resectable by hyperthermo-chemo-radiotherapy].
    Fujimura T; Yonemura Y; Kamata T; Takegawa S; Sugiyama K; Nishimura G; Miyata R; Yamaguchi A; Miyazaki I; Nakajima K
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1322-7. PubMed ID: 3430022
    [No Abstract]   [Full Text] [Related]  

  • 60. Should cetuximab replace cisplatin in head and neck cancer?
    Rowan K
    J Natl Cancer Inst; 2010 Jan; 102(2):74-6, 78. PubMed ID: 20054019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.